Ribavirin reduces subsequent reactive airway disease in infants with bronchiolitis

Reduced long-term respiratory morbidity

Reduced long-term respiratory morbidity after treatment of respiratory syncytial virus bronchiolitis with ribavirin in previously healthy infants: A preliminary report

✍ Dean Edell; Erik Bruce; Kathe Hale; Debra Edell; Vikram Khoshoo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

Previously healthy infants less than 6 months of age with severe respiratory syncytial virus bronchiolitis who required hospitalization were identified from hospital records. Infants had been treated either conservatively (control group, n = 19) or with ribavirin added to conservative management (st